BI-749327

N/A

Report date: 2026/01/08 17:58:17
NME

Base Information

Drug NameBI-749327
Drug Alias NameBI-749327
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 6 antagonists
TargetsTransient receptor potential cation channel subfamily V member 6
Therapy Area/IndicationsRenal fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Corp
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsRenal fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A